Fundraising FoxFrist Cressey Ventures — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
Aradigm develops financial and delivery infrastructure for cell and gene therapies, partnering with payers, providers, manufacturers, and patients to enable sustainable access to transformative treatments through a pass-through business model.
BiotechDigital HealthHealthtechMedical DevicesHayward, US
Igor Gonda(Executive Officer, Director)Nancy E. Pecota(Executive Officer)
BoardWill Shrank, M.D.(CEO)inVirgil D. Thompson(Director)David Bell(Director)John M. Siebert(Director)
Co-investorsAndreessen Horowitz
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
MDSave Shared Services
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.